Viewing Study NCT02545361


Ignite Creation Date: 2025-12-24 @ 11:48 AM
Ignite Modification Date: 2026-02-05 @ 1:47 PM
Study NCT ID: NCT02545361
Status: WITHDRAWN
Last Update Posted: 2018-08-16
First Post: 2015-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, and Anti-cancer Activity of KAHR-102 (The Study Drug) for the Treatment of Lymphoma Patients
Sponsor: Kahr Medical
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module